COMMUNIQUÉS West-GlobeNewswire

Le Hemp Energy Drink arrive en magasin!

18/02/2019 - 14:00

ORLEANS, Ontario, 18 févr. 2019 (GLOBE NEWSWIRE) -- Tetra Santé Naturelle, une filiale de Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), annonce que les canettes de Hemp Energy Drink sont maintenant disponibles [...]

Rejuvenate Reverses Muscle Loss From Aging Without Exercise

18/02/2019 - 14:00

BURLINGTON, Ontario, Feb. 18, 2019 (GLOBE NEWSWIRE) -- Middle-aged adults are failing in the fight against frailty. Health officials say age-related muscle and strength loss, or sarcopenia, will affect every man and [...]

BioCryst to Report Fourth Quarter and Full Year 2018 Financial Results on March 4

18/02/2019 - 13:00

RESEARCH TRIANGLE PARK, N.C., Feb. 18, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its fourth quarter and full year 2018 financial results on [...]

CampDoc Partners with QuattroC to Offer Integrated Solution for JCCs and YMCAs

18/02/2019 - 12:00

ANN ARBOR, Mich., Feb. 18, 2019 (GLOBE NEWSWIRE) -- CampDoc, the leading electronic health record system for camps , has partnered with Applications Research Corporation, the creators of eFinesstri, and a leading [...]

Align Technology Launches New iTero Element 5D Imaging System for Comprehensive Preventative and Restorative Oral Care at IDS

18/02/2019 - 12:00

SAN JOSE, Calif., Feb. 18, 2019 (GLOBE NEWSWIRE) -- First intraoral scanner with near-infrared imaging (NIRI) technology that scans the internal structure of a tooth (enamel & dentin) in real time 1 . First [...]

Lundbeck increases its share capital by 5,631 shares (0.0028 % of outstanding shares) as a result of exercise of employee warrants

18/02/2019 - 09:46

Valby, Denmark, 18 February 2019 - H. Lundbeck A/S (Lundbeck) today announced that it has decided to increase its share capital by DKK 28,155 as a consequence of the exercise of employee warrants. The increase is [...]

Aino Health AB (publ): Aino HealthManager deployed for global company

18/02/2019 - 08:31

18 February 2019 Aino Health's SaaS solution HealthManager has been deployed in two countries for a global company in customer service. It is a joint implementation project conducted by the client and Aino Health for [...]

Saniona’s SAN711 selected for clinical studies in itching and pain

18/02/2019 - 08:00

PRESS RELEASE February 18, 2019 SAN711 has achieved preclinical validation and met other requirements for clinical study First in class compound offers a new treatment paradigm for itching and neuropathic pain Targeting [...]

Motif BioSciences Enters into Amendment Agreement with Hercules Capital

18/02/2019 - 08:00

NEW YORK, Feb. 18, 2019 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that Motif BioSciences Inc. (a [...]

Biophytis Announces Three Oral and One Poster Presentations at the 2019 International Conference on Frailty and Sarcopenia Research

18/02/2019 - 07:00

ICFSR 2019 will take place Feb. 20-22, 2019 in Miami Beach, FL PARIS, Feb. 18, 2019 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of [...]

Medtronic Announces Preliminary PRODIGY Results: a Global Study to Identify Patients at High Risk for Opioid-Induced Respiratory Compromise

18/02/2019 - 00:46

Groundbreaking Microstream(TM) Capnography Study Provides Easy-to-Use Risk Prediction Tool Study Found Greater Than 40 Percent of Patients on Hospital General Care Floor Experience Opioid- Induced Respiratory Depression [...]

REVA Announces Trading Halt

17/02/2019 - 23:43

SAN DIEGO, Feb. 17, 2019 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) said today that on 18 February 2019 (AEDT), the Australian Securities Exchange issued a market announcement indicating [...]

Updated Results from Phase 1 Study of Telaglenastat (CB-839) to be Presented at 2019 ASCO Genitourinary Cancer Symposium

16/02/2019 - 12:00

-- Clinical study explored Calithera’s lead compound in combination with cabozantinib in patients with advanced renal cell carcinoma - SOUTH SAN FRANCISCO, Calif., Feb. 16, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences [...]

Acarix adapts pathway for German reimbursement - Submission of new dossier by the end of February 2019

15/02/2019 - 20:31

Press release Malmö, February 15, 2019 Acarix adapts pathway for German reimbursement - Submission of new dossier by the end of February 2019 Acarix AB (publ) (ACARIX: FN Stockholm) today announced it will file for [...]

Kiadis Pharma Notice of Extraordinary General Meeting of Shareholders

15/02/2019 - 20:07

Amsterdam, The Netherlands, 15 February 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces that it has [...]

Sienna Announces February Dividend

15/02/2019 - 18:25

MARKHAM, Ontario, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.0765 per common share of the Company (each, a “Common Share”) for [...]

HEXO Corp. enters into $65 million bank debt facility

15/02/2019 - 18:12

GATINEAU, Quebec, Feb. 15, 2019 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX: HEXO ; NYSE-A: HEXO ) is pleased to announce it has entered into a syndicated credit facility with Canadian Imperial Bank of [...]

HEXO Corp conclut une facilité de crédit bancaire de 65 millions de dollars

15/02/2019 - 18:12

GATINEAU, Québec, 15 févr. 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX: HEXO ; NYSE-A : HEXO ) a le plaisir d’annoncer la conclusion d’une facilité de crédit syndiquée auprès de la Banque [...]

ORYZON Reports Financial Results and Corporate Update for the 4th Quarter and Year Ended December 31, 2018

15/02/2019 - 17:41

-$0.04/share for the 12 months ended December 31st MADRID, Spain and CAMBRIDGE, Mass., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical [...]